IDH2 and central nervous system cancer: Although IDH mutations are believed to drive glioma initiation by producing (R)2-HG, which results in DNA hypermethylation and metabolic reprograming [35–37], expression of mutant Idh1 in the mouse brain has yet to induce glioma formation despite robust production of (R)2-HG [11, 38].